 LAVAL, Québec, Jan. 13, 2023 GLOBE NEWSWIRE -- Acasti Pharma Inc. Acasti or the Company Nasdaq: ACST and TSX-V: ACST, a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced Jan Dalvise, CEO, will present and host one-on-one meetings with investors at the Sidoti January Virtual Investor Conference, taking place on January 18-19, 2023. 